BD held a grand opening ceremony for a new €4 million research and development facility in Blackrock, Dublin on Friday.
Joining BD executives at the grand opening ceremony were Minister of State for the Department of Enterprise, Trade and Employment, Neale Richmond and IDA Executive Director, Mary Buckley.
85 New Jobs
The global medical technology company announced an additional €30 million investment to expand its manufacturing facility in Enniscorthy, Wexford.
The two investments will create more than 85 new jobs in Ireland.
BD Evolve On-Body Injector
The new 10,600 sq. ft. purpose-built R&D facility in Blackrock will house 35 high-tech workers and complements BD’s R&D facility in Limerick, which employs more than 300 people.
The facility will focus on the commercialisation of BD’s first on-body injector device, known as the BD Evolve On-Body Injector.
With the majority of new pharmaceuticals in the pipeline being injectable drugs, BD has innovated new injection devices to meet this growing need. The facility will also serve as the regional base of operations for BD’s Sales, Technical Service and Corporate Functional Support Teams.
Enniscorthy Expansion
BD officials also announced a new €30 million investment to expand its existing manufacturing facility in Enniscorthy, which will create approximately 85 new jobs.
The new 40,000 sq. ft. expansion will house operations to manufacture a new medical technology from BD’s Peripheral Intervention business unit.
'Exciting New Medical Advancements'
“I am delighted with BD's announcement of a €4 million research and development facility in Blackrock, Dublin and additional €30 million expansion investment in Enniscorthy, Wexford,"
Minister of State for the Department of Enterprise, Trade and Employment, Neale Richmond TD.
"The projects will create more than 85 new jobs in Ireland with opportunities for our talented workforce to be part of exciting new medical advancements at BD."
Source: www.businessworld.ie